Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
Background: The roadmap approach is recommended to guide chronic hepatitis B treatment. We evaluated the cost-effectiveness of various treatment strategies in the global market. Methods: Lamivudine and telbivudine were tested in roadmap models with switch-to tenofovir if HBV was detectable at week 2...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
International Medical Press
2010
|
| Subjects: |